STOCK TITAN

Accenture plc (ACN) SEC Filings, Jan 6-15, 2026

ACN NYSE

Accenture plc filings document the regulatory record of a global professional services company, including operating results, material events, governance matters and capital-structure disclosures. The company’s 8-K reports cover quarterly and annual financial results, non-GAAP measures such as free cash flow and local-currency revenue and bookings, and material financing arrangements including senior unsecured revolving credit facilities used for general corporate purposes and to support its commercial paper program.

Proxy materials describe shareholder voting matters, board and executive compensation disclosures, equity award information and governance practices. Other filings record leadership and organizational changes, including Accenture’s integrated Reinvention Services business unit, as well as risk, liquidity and financial reporting topics relevant to its consulting, technology and operations services model.

Rhea-AI Summary

Accenture plc Chief Strategy & Services Officer Manish Sharma reported several open-market sales of Class A ordinary shares on January 14, 2026 under a pre-arranged Rule 10b5-1 trading plan. The transactions, all coded as sales, were executed at prices ranging from about $276.61 to $290.21 per share. After these trades, Sharma directly owned 7,057 Accenture Class A ordinary shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
insider
-
Rhea-AI Summary

Accenture plc’s Chair and CEO, Julie Sweet, reported a planned sale of company stock. On January 14, 2026, she sold a total of 1,694 Class A ordinary shares of Accenture plc in a series of open-market transactions at prices ranging from $276.61 to $290.915 per share. The filing states these dispositions were made under a pre-established Rule 10b5-1 trading plan, which allows trades to occur according to preset instructions. After these transactions, she directly held 37,346 Class A ordinary shares of Accenture.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
insider
-
Rhea-AI Summary

A Form 144 notice reports that an affiliate of ACN, Manish Sharma, plans to sell 2,731 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $786,870.47. The issuer has 660,432,542 shares of this class outstanding.

The shares to be sold were acquired from the issuer as stock awards on multiple dates in 2025 and 2026, including a grant of 1,502 shares on 12/05/2025. The filing also notes a prior sale by Manish Sharma of 6,902 Class A Ordinary shares on 10/22/2025, for gross proceeds of $1,725,546.93.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

A person named Mauro Macchi has filed a Form 144 notice to sell 500 Class A Ordinary shares of the issuer through UBS Financial Services, Inc. on the NYSE, with an approximate sale date of 01/14/2026. The aggregate market value for this planned sale is listed as 140000.00, and the issuer reports 660432542 shares outstanding.

The securities to be sold were acquired on 10/20/2025 as a stock award from the issuer, with 500 securities acquired on that date. The notice also reports that during the past three months, Mauro Macchi sold an additional 500 Class A Ordinary shares on 01/07/2026 for gross proceeds of 140000.00. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Julie Sweet has filed a Form 144 to sell up to 1,694 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services on the NYSE, with an aggregate market value of $468,577.34. The issuer has 660,432,542 shares outstanding, providing context for the size of this transaction.

The shares to be sold were acquired as stock awards from the issuer, including 158 shares on 11/14/2025 and 1,536 shares on 01/05/2026. Over the past three months, Julie Sweet has already sold Class A Ordinary shares in several transactions, including 9,000 shares for gross proceeds of $2,246,165.10, 9,000 shares for $2,280,587.40, and 5,917 shares for $1,459,276.57. By signing the notice, the seller represents that she does not know of any undisclosed material adverse information about the issuer’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Accenture plc executive Mauro Macchi, Chief Executive Officer-EMEA, reported a planned sale of company stock. On January 7, 2026, he disposed of 500 Class A ordinary shares of Accenture at a price of $280 per share in a transaction coded "S" for sale. The transaction was carried out pursuant to a Rule 10b5-1 trading plan, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Following this sale, Macchi directly beneficially owns 7,623 Class A ordinary shares of Accenture.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A holder of 500 Class A Ordinary shares has filed notice to sell these securities of issuer ACN through UBS Financial Services, Inc. on the NYSE. The planned sale has an aggregate market value of 140000.00 and is referenced against 660,432,542 shares outstanding.

The seller acquired the 500 shares on 10/20/2025 as a stock award from the issuer, with the same date listed as the payment date and the nature of payment marked as “N/A,” indicating no separate cash purchase. The approximate proposed sale date is 01/07/2026. The form also includes a representation that the seller is not aware of undisclosed material adverse information about the issuer’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Accenture plc’s general counsel and corporate secretary, Joel Unruch, reported a sale of Class A ordinary shares. On 01/06/2026, he disposed of 1,332 Class A ordinary shares of Accenture at a price of $275 per share, coded as a sale transaction. The filing notes this was a planned disposition made under a Rule 10b5-1 trading plan, which is a pre-arranged program for buying or selling shares.

Following this transaction, Unruch directly beneficially owns 28,207 Accenture Class A ordinary shares. The report is filed as a Form 4 for a single reporting person and reflects his status as an officer of the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
insider
-
Rhea-AI Summary

A holder of ACN stock has filed a notice of proposed sale under Rule 144 for 1,332 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services, Inc. on the NYSE, with an aggregate market value of 366,300.00 based on the filer’s calculation. The filing lists 660,432,542 shares of this class as outstanding.

The shares to be sold were acquired as stock awards from the issuer, with 541 shares granted on 01/01/2024 and 791 shares granted on 10/20/2025, both shown as non-cash awards. The approximate sale date indicated is 01/06/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
other
Rhea-AI Summary

Accenture plc executive John F. Walsh, CEO-The Americas, reported multiple Class A ordinary share transactions. On 01/05/2026, he acquired 104 Class A ordinary shares from Accenture at $263.1125 per share under the Accenture Voluntary Equity Investment Program. He also received a grant of 1,656 Class A ordinary shares at a price of $0, also pursuant to the same program.

The filing shows a separate disposition of 420 Class A ordinary shares on 01/05/2026, coded "F", at a price of $263.1125 per share. After these transactions, Walsh beneficially owned 31,207 Class A ordinary shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
insider

FAQ

How many Accenture plc (ACN) SEC filings are available on StockTitan?

StockTitan tracks 348 SEC filings for Accenture plc (ACN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Accenture plc (ACN)?

The most recent SEC filing for Accenture plc (ACN) was filed on January 15, 2026.